No Data
No Data
No Data
No Data
No Data
泰達生物:二零二三年年報
Futu NewsApr 19 16:41 · Announcements
Teda Biotech (08189) proposes to appoint Tu Xiangzhen as an independent non-executive director
Teda Biotech (08189) announced that Mr. Li Xudong has resigned as an independent non-executive director and will no longer serve on the company's audit committee...
Zhitong FinanceMar 29 04:08
TEDA BIOMEDICAL: ANNOUNCEMENT ON ANNUAL RESULTS FOR 2023
Futu NewsMar 28 22:58 · Announcements
Teda Biotech (08189.HK) plans to sell 82.76% of Shanghai Weidi's shares for 10.593 million yuan
Gelonghui, March 27, 丨 Teda Biotech (08189.HK) announced that on January 31, 2024, the company signed an equity transfer agreement. Based on this, the company agreed to sell 82.76% of Shanghai Weidi's shares to the buyer at a cost of RMB 10.593 million. After completion, the company will still hold 17.24% of Shanghai Weidi's shares. In view of Shanghai Weidi's performance over the past two years and uncertainty about future prospects, the board of directors believes that the sale is a good opportunity for the company to monetize its investment in Shanghai. Additionally, considering the proceeds from the sale, the company is able to reallocate its resources to its existing
Gelonghui FinanceMar 27 17:41
Teda Biotech (08189): Qin Wenhua Resigns as Co-CEO
Zhitong Finance App News, Teda Biotech (08189) issued an announcement. Qin Wenhua has resigned as Co-CEO due to busy affairs and other personal reasons, effective March 26, 2024.
Zhitong FinanceMar 26 18:14
Huatai Securities: The silver economy may spawn a series of investment opportunities from the capital side, demand side, and supply side
As China's aging deepens, the introduction of the first banking economic policy may spawn a series of investment opportunities from the demand side, supply side, and capital side.
Zhitong FinanceFeb 27 15:57
No Data
No Data